Bio Techne | TECH - Selling And Administration Expenses

Stock Price
43.30
Daily Change
-1.44 -3.22%
Monthly
-24.51%
Yearly
-11.90%
Q2 Forecast
47.36

Bio Techne reported $109.34M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Agilent USD 476M 48M Dec/2025
Becton, Dickinson and Co. USD 1.21B 180M Mar/2026
Bio Techne USD 109.34M 4.35M Mar/2026
Bio-Rad Laboratories USD 221M 14.2M Dec/2025
Bruker USD 242.1M 5.1M Mar/2026
Charles River Laboratories USD 159.42M 36.71M Mar/2026
Danaher USD 1.86B 166M Mar/2026
Illumina USD 272M 11M Mar/2026
IQVIA Holdings USD 502M 34M Mar/2026
Merck EUR 1.6B 136M Dec/2025
Mettler Toledo International USD 258.33M 1.5M Mar/2026
OraSure Technologies USD 13.21M 3.29M Dec/2025
Pacific Biosciences Of California USD 37.24M 25.68M Dec/2025
Repligen USD 76.54M 2.17M Mar/2026
Revvity USD 253.88M 2.15M Mar/2026
Standard Biotools USD 21.55M 5.05M Dec/2025
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Waters USD 394M 153.99M Mar/2026